Mediastinal and supraclavicular lymphadenitis and pneumonitis due to Chlamydia trachomatis serovars L1 and L2.
D000328:Adult; D000907:Antibodies, Bacterial / Q000032:analysis; D002690:Chlamydia Infections / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D002692:Chlamydia trachomatis / Q000276:immunology; D002968:Clavicle; D004917:Erythromycin / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007757:Laboratory Infection / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D008199:Lymphadenitis / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D008297:Male; D008482:Mediastinum; D008875:Middle Aged; D011014:Pneumonia / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D012703:Serotyping; D013754:Tetracyclines / Q000627:therapeutic use
D000907:Antibodies, Bacterial; D013754:Tetracyclines; D004917:Erythromycin